Delayed Nyse 04:02:24 2023-09-21 pm EDT |
|
5-day change | 1st Jan Change | |
125.35 USD | -2.06% | -2.74% | +22.60% |
Sep. 12 | Celanese Working With Population Council to Supply VitalDose Drug Delivery Platform | MT |
Sep. 07 | North American Morning Briefing: Concerns About -2- | DJ |
Financials (USD)
Sales 2023 * | 11,194 M | Sales 2024 * | 11,841 M | Capitalization | 13 645 M |
---|---|---|---|---|---|
Net income 2023 * | 760 M | Net income 2024 * | 1,274 M | EV / Sales 2023 * | 2,27x |
Net Debt 2023 * | 11,811 M | Net Debt 2024 * | 10,836 M | EV / Sales 2024 * | 2,07x |
P/E ratio 2023 * | 17,2x | P/E ratio 2024 * | 10,5x | Employees | - |
Yield 2023 * | 2,21% | Yield 2024 * | 2,32% | Free-Float | 63.62% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
1 day | -2.06% | ||
1 week | -2.74% | ||
Current month | -0.80% | ||
1 month | +6.22% | ||
3 months | +15.51% | ||
6 months | +19.19% | ||
Current year | +22.60% |
1 week
125.33
131.05

1 month
116.32
131.05

Current year
97.12
131.05

1 year
86.71
131.05

3 years
86.71
176.50

5 years
52.70
176.50

10 years
48.78
176.50

Managers | Title | Age | Since |
---|---|---|---|
Lori Ryerkerk
CEO | Chief Executive Officer | 60 | 2019 |
Scott Richardson
DFI | Director of Finance/CFO | - | 2018 |
Anne Puckett
LAW | General Counsel | 61 | 2019 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Brown
BRD | Director/Board Member | 60 | 2015 |
Lori Ryerkerk
CHM | Chairman | 60 | 2020 |
Edward Galante
BRD | Director/Board Member | 72 | 2013 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.56% | 3,168 M$ | -6.12% | ||
0.53% | 30 M$ | +8.40% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-09-21 | 125.35 | -2.06% | 1,111,304 |
23-09-20 | 127.99 | -0.24% | 787,943 |
23-09-19 | 128.30 | -0.54% | 928,456 |
23-09-18 | 129.00 | +0.59% | 987,756 |
23-09-15 | 128.24 | -0.50% | 1,212,785 |
Delayed Quote Nyse, September 21, 2023 at 04:02 pm EDT
More quotes
Celanese Corporation specializes in the manufacture and marketing of chemicals and specialty materials. The products are intended for the production of automotive components, beverages and food products, cigarette filters, paints and coatings, packaging, textiles, etc. Net sales by category of products break down as follows:
- acetyl products (62.7%);
- high performance engineering polymers (31.4%);
- cellulose acetate cables (5.9%).
Net sales are distributed geographically as follows: the United States (23.5%), Germany (31.3%), China (19%), Singapore (14.1%), Mexico (3.9%), Belgium (3.1%), Switzerland (1.6%), Canada (1.1%) and other (2.4%).
Sector
Commodity Chemicals
Calendar
2023-10-22
- Q3 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
125.35USD
Average target price
133.46USD
Spread / Average Target
+6.47%
EPS Revisions
1st Jan change | Capi. (M$) | |
---|---|---|
+22.60% | 13 645 M $ | |
-5.80% | 14 093 M $ | |
+17.48% | 14 192 M $ | |
-15.00% | 12 480 M $ | |
-31.00% | 11 939 M $ | |
+18.03% | 15 454 M $ | |
+7.00% | 15 455 M $ | |
-35.40% | 11 685 M $ | |
-3.09% | 16 055 M $ | |
-5.63% | 16 512 M $ |